Status:
UNKNOWN
Fecal Immunochemical Test for Advanced Adenoma Detection in Colorectal Cancer Screening
Lead Sponsor:
Shandong University
Collaborating Sponsors:
The People's Hospital of Zhaoyuan City
Shanghe People's Hospital
Conditions:
Colorectal Cancer
Colorectal Neoplasms
Eligibility:
All Genders
50-75 years
Brief Summary
Early detecting and removing of colorectal advanced adenomas can reduce incidence of colorectal cancer. In order to reduce the incidence of colorectal cancer, improve the early diagnosis of colorectal...
Detailed Description
Colorectal cancer accounts for approximately 10% of all annually diagnosed cancers and cancer-related deaths worldwide. With progress of developing countries, it is predicted that the incidence of col...
Eligibility Criteria
Inclusion
- Adults 50-75 years old
Exclusion
- People with history of intestinal surgery;
- People with history of colorectal cancer;
- People with history of inflammatory bowel disease, ischemic enteritis, vascular malformation of intestine or other disease resulting in intestinal tract bleeding;
- People with symptoms including visible rectal bleeding, hematuria, severe and acute diarrhea;
- Pregnancy, lactation or menstrual phase;
- Severe congestive heart failure or other sever disease cause cannot tolerate colonoscopy.
Key Trial Info
Start Date :
January 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT05200611
Start Date
January 4 2022
End Date
July 1 2022
Last Update
January 21 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghe People's Hospital
Jinan, Shandong, China, 250012
2
The People's Hospital of Zhaoyuan City
Yantai, Shandong, China